Pharmacoeconomic analysis of the etravirine compared to raltegravir in treatment HIV-infected adult patients, previously treated with antiretroviral drugs

Pharmacoeconomic analysis of the etravirine compared to raltegravir in treatment HIV-infected adult patients, previously treated with antiretroviral drugs

Objective: To perform comprehensive pharmacoeconomical assessment of use etravirine and raltegravir in HIV-infected patients. Methodology: Cost-eifectiveness and budget impact analyses of etravirine or raltegravir on the top of optimized background therapy in adult treatment-experienced HIV-infected...

Full description

Bibliographic Details
Main Authors: Y. I. Ashikhmin, D. Yu. Belousov
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2018-05-01
Series:Качественная клиническая практика
Subjects:
фармакоэкономический анализ
анализ эффективности затрат
анализ влияния на бюджет
вич-инфекция
антиретровирусная терапия
этравирин
ралтегравир
pharmacoeconomics
cost-effectiveness analysis
budget impact analysis
hiv-infection
antiretroviral therapy
etravirine
raltegravir
Online Access:https://www.clinvest.ru/jour/article/view/27

Internet

https://www.clinvest.ru/jour/article/view/27

Similar Items